Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse Ovaries

Ovarian aging hampers in vitro fertilization in assisted reproductive medicine and has no cure. Lipoprotein metabolism is associated with ovarian aging. It remains unclear how to overcome poor follicular development with aging. Upregulation of the low-density lipoprotein receptor (LDLR) enhances oog...

Full description

Bibliographic Details
Main Authors: Yu Jin Kim, Yong Il Cho, JuYi Jang, Yun Dong Koo, Sung Woon Park, Jae Ho Lee
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/8/7263
_version_ 1797605059062661120
author Yu Jin Kim
Yong Il Cho
JuYi Jang
Yun Dong Koo
Sung Woon Park
Jae Ho Lee
author_facet Yu Jin Kim
Yong Il Cho
JuYi Jang
Yun Dong Koo
Sung Woon Park
Jae Ho Lee
author_sort Yu Jin Kim
collection DOAJ
description Ovarian aging hampers in vitro fertilization in assisted reproductive medicine and has no cure. Lipoprotein metabolism is associated with ovarian aging. It remains unclear how to overcome poor follicular development with aging. Upregulation of the low-density lipoprotein receptor (LDLR) enhances oogenesis and follicular development in mouse ovaries. This study investigated whether upregulation of LDLR expression using lovastatin enhances ovarian activity in mice. We performed superovulation using a hormone and used lovastatin to upregulate LDLR. We histologically analyzed the functional activity of lovastatin-treated ovaries and investigated gene and protein expression of follicular development markers, using RT-qPCR and Western blotting. Histological analysis showed that lovastatin significantly increased the numbers of antral follicles and ovulated oocytes per ovary. The in vitro maturation rate was 10% higher for lovastatin-treated ovaries than for control ovaries. Relative LDLR expression was 40% higher in lovastatin-treated ovaries than in control ovaries. Lovastatin significantly increased steroidogenesis in ovaries and promoted the expression of follicular development marker genes such as anti-Mullerian hormone, Oct3/4, Nanog, and Sox2. In conclusion, lovastatin enhanced ovarian activity throughout follicular development. Therefore, we suggest that upregulation of LDLR may help to improve follicular development in clinical settings. Modulation of lipoprotein metabolism can be used with assisted reproductive technologies to overcome ovarian aging.
first_indexed 2024-03-11T04:55:48Z
format Article
id doaj.art-1a6fdcaa154948d396846a5b84a5fcfa
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T04:55:48Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1a6fdcaa154948d396846a5b84a5fcfa2023-11-17T19:37:47ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-04-01248726310.3390/ijms24087263Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse OvariesYu Jin Kim0Yong Il Cho1JuYi Jang2Yun Dong Koo3Sung Woon Park4Jae Ho Lee5CHA Fertility Center Seoul Station, Seoul 04637, Republic of KoreaWonju Severance Christian Hospital, Wonju 22070, Republic of KoreaDepartment of Biomedical Sciences, CHA University, Pocheon 11160, Republic of KoreaDepartment of Biomedical Sciences, CHA University, Pocheon 11160, Republic of KoreaCHA Fertility Center Seoul Station, Seoul 04637, Republic of KoreaCHA Fertility Center Seoul Station, Seoul 04637, Republic of KoreaOvarian aging hampers in vitro fertilization in assisted reproductive medicine and has no cure. Lipoprotein metabolism is associated with ovarian aging. It remains unclear how to overcome poor follicular development with aging. Upregulation of the low-density lipoprotein receptor (LDLR) enhances oogenesis and follicular development in mouse ovaries. This study investigated whether upregulation of LDLR expression using lovastatin enhances ovarian activity in mice. We performed superovulation using a hormone and used lovastatin to upregulate LDLR. We histologically analyzed the functional activity of lovastatin-treated ovaries and investigated gene and protein expression of follicular development markers, using RT-qPCR and Western blotting. Histological analysis showed that lovastatin significantly increased the numbers of antral follicles and ovulated oocytes per ovary. The in vitro maturation rate was 10% higher for lovastatin-treated ovaries than for control ovaries. Relative LDLR expression was 40% higher in lovastatin-treated ovaries than in control ovaries. Lovastatin significantly increased steroidogenesis in ovaries and promoted the expression of follicular development marker genes such as anti-Mullerian hormone, Oct3/4, Nanog, and Sox2. In conclusion, lovastatin enhanced ovarian activity throughout follicular development. Therefore, we suggest that upregulation of LDLR may help to improve follicular development in clinical settings. Modulation of lipoprotein metabolism can be used with assisted reproductive technologies to overcome ovarian aging.https://www.mdpi.com/1422-0067/24/8/7263LDLRlovastatinfollicular developmentoocytesin vitro maturation
spellingShingle Yu Jin Kim
Yong Il Cho
JuYi Jang
Yun Dong Koo
Sung Woon Park
Jae Ho Lee
Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse Ovaries
International Journal of Molecular Sciences
LDLR
lovastatin
follicular development
oocytes
in vitro maturation
title Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse Ovaries
title_full Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse Ovaries
title_fullStr Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse Ovaries
title_full_unstemmed Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse Ovaries
title_short Lovastatin, an Up-Regulator of Low-Density Lipoprotein Receptor, Enhances Follicular Development in Mouse Ovaries
title_sort lovastatin an up regulator of low density lipoprotein receptor enhances follicular development in mouse ovaries
topic LDLR
lovastatin
follicular development
oocytes
in vitro maturation
url https://www.mdpi.com/1422-0067/24/8/7263
work_keys_str_mv AT yujinkim lovastatinanupregulatoroflowdensitylipoproteinreceptorenhancesfolliculardevelopmentinmouseovaries
AT yongilcho lovastatinanupregulatoroflowdensitylipoproteinreceptorenhancesfolliculardevelopmentinmouseovaries
AT juyijang lovastatinanupregulatoroflowdensitylipoproteinreceptorenhancesfolliculardevelopmentinmouseovaries
AT yundongkoo lovastatinanupregulatoroflowdensitylipoproteinreceptorenhancesfolliculardevelopmentinmouseovaries
AT sungwoonpark lovastatinanupregulatoroflowdensitylipoproteinreceptorenhancesfolliculardevelopmentinmouseovaries
AT jaeholee lovastatinanupregulatoroflowdensitylipoproteinreceptorenhancesfolliculardevelopmentinmouseovaries